(Q38786224)

6 September 2017

Behçet's Disease and Nervous System Involvement (English)

1 reference

6 September 2017

0 references

Murat Kürtüncü

1

1 reference

PubMed ID

27007988

6 September 2017

Erdem Tüzün

series ordinal

2

1 reference

PubMed ID

27007988

6 September 2017

Gulsen Akman-Demir

series ordinal

3

1 reference

6 September 2017

1 May 2016

1 reference

Current treatment options in neurology

6 September 2017

1 reference

6 September 2017

18

1 reference

6 September 2017

5

1 reference

6 September 2017

19

1 reference

https://scigraph.springernature.com/pub.10.1007/s11940-016-0405-6

6 September 2017

0 references

cites work

Pathogenesis of Behçet's disease: autoinflammatory features and beyond

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Behçet's disease--a contemporary review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Behçet's syndrome and micro-organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Behçet's syndrome: facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

21 January 2018

Neuro-Behçet syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Does hepcidin play a role in the pathogenesis of aphthae in Behçet's disease and recurrent aphthous stomatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Etiopathology of Behçet's disease: immunological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

The role of infections in Behçet disease and neuro-Behçet syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

A possible role for interleukin 37 in the pathogenesis of Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Immunology and functional genomics of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Familial aggregation in Behçet's disease: high frequency in siblings and parents of pediatric probands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Pathological implications of Th1/Th2 cytokine genetic variants in Behçet's disease: Data from a pilot study in a Sicilian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Predisposition to Behçet's disease and VKH syndrome by genetic variants of miR-182.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Association of Pre-miRNA-499 rs3746444 and Pre-miRNA-146a rs2910164 Polymorphisms and Susceptibility to Behcet's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Neuro-Behçet disease. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Headache in Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

An outcome survey of 43 patients with Budd-Chiari syndrome due to Behçet's syndrome followed up at a single, dedicated center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Cerebral vasculitis and ischaemic stroke in Behçet's disease: report of one case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Neuropsychological follow-up of 12 patients with neuro-Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

A case study of neuro-psycho-Behçet's syndrome presenting with psychotic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Neuro-Behcet's disease presenting with amnesia and frontal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Pitfalls in the diagnosis of Neuro-Behcet presenting with psychiatric symptoms at onset: a case report!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Pseudotumoural presentation of neuro-Behcet's disease: case series and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Neuro-Behçet's disease with chorea after remission of intestinal Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Cranial MRI in Behçet's disease: 134 examinations of 98 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Masked assessment of MRI findings: is it possible to differentiate neuro-Behçet's disease from other central nervous system diseases? [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Cerebral venous thrombosis in Behçet's disease compared to those associated with other etiologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Clinical characteristics of pediatric-onset neuro-Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Long-term outcome of neuro-Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Retrospective analysis of long-term outcome of chronic progressive neurological manifestations in Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Effect of infliximab in progressive neuro-Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Efficacy of infliximab in neuro-Behçet's disease presenting with isolated longitudinally extensive transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Infliximab monotherapy for neuro-Behçet's disease: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Tocilizumab for severe refractory neuro-Behçet: three cases IL-6 blockade in neuro-Behçet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Interferon-alpha 2a treatment of neuro-Behcet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Prolonged remission of neuro-Behcet disease following autologous transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

A neuro-Behçet's case complicated with intracranial hypertension successfully treated by a lumboperitoneal shunt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Gene polymorphisms involved in manifestation of leucopenia, digestive intolerance, and pancreatitis in azathioprine-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behçet's Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Tumor necrosis factor-α antagonists: Side effects and their management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Association study of IL10 and IL23R-IL12RB2 in Iranian patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Anakinra treatment in drug-resistant Behcet’s disease: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0405-6

Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet's disease: an updated meta-analysis

21 January 2018

1 reference

12 December 2020

A functional variant of pre-miRNA-196a2 confers risk for Behcet's disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis

1 reference

12 December 2020

Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab

1 reference

12 December 2020

Ataxia and cerebellar atrophy--a novel manifestation of neuro-Behçet disease?

1 reference

12 December 2020

Adalimumab for the treatment of Japanese patients with intestinal Behçet's disease

1 reference

12 December 2020

1 reference

12 December 2020

[Neuro-Behçet and neurotoxicity due to cyclosporine]

1 reference

12 December 2020

Refractory neuro-Behçet treated by tocilizumab: a case report

1 reference

12 December 2020

1 reference

12 December 2020

Coexistence of Guillain-Barré syndrome and Behçet's disease

1 reference

12 December 2020

Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years

1 reference

12 December 2020

Seven-year follow-up of neurologic involvement in Behçet syndrome

1 reference

12 December 2020

Pediatric neuro-Behçet's disease responsive to adalimumab

1 reference

12 December 2020

Intrathecal oligoclonal IgG bands are infrequently found in neuro-Behçet's disease

1 reference

12 December 2020

Interferon-alpha for the treatment of severe entero- and neuro-Behçet's disease

1 reference

12 December 2020

Tocilizumab treatment for neuro-Behcet's disease, the first report

1 reference

12 December 2020

Etanercept in the treatment of intestinal Behcet's disease

1 reference

12 December 2020

Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.

1 reference

12 December 2020

Phenotypic abnormalities of peripheral blood mononuclear cells in patients with Behçet's disease and association with HLA-B51 expression

1 reference

12 December 2020

Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.

1 reference

12 December 2020

Analysis of 27 cases of large vascular lesions in 161 cases of Behcet's disease: clinical manifestations and treatment outcome

1 reference

12 December 2020

Genetics of Behçet's Disease.

1 reference

12 December 2020

Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behçet's disease with parenchymal involvement: presentation of four cases

1 reference

12 December 2020

Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behçet's disease

1 reference

12 December 2020

Spontaneous dissection of the extracranial vertebral artery with spinal subarachnoid haemorrhage in a patient with Behçet's disease

1 reference

12 December 2020

Clinical characteristics and course of spinal cord involvement in Behçet's disease

1 reference

12 December 2020

Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome

1 reference

12 December 2020

Cyclosporine for Behçet's uveitis: is it associated with an increased risk of neurological involvement?

1 reference

12 December 2020

Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases

1 reference

12 December 2020

Successful treatment of severe Behçet's disease with infliximab in an Italian Olympic athlete.

1 reference

12 December 2020

10.1007/S11940-016-0405-6

Identifiers

DOI

1 reference

6 September 2017

1 reference

PubMed ID

27007988